Imax price target raised to $37 from $32 at Barrington

Barrington raised the firm’s price target on Imax (IMAX) to $37 from $32 and keeps an Outperform rating on the shares following meetings with management. The firm cites its outlook for continued box office growth for the target increase. The demand for a premium experience has supported the increased box office share for Imax, the analyst tells investors in a research note. Barrington believes expanded content offerings can benefit the company over the long term.